X-Energy (NASDAQ:XE) just earned coverage from six major Wall Street firms, with five taking a bullish stance on the advanced nuclear developer. Guggenheim set the high bar with a Buy rating and a $57 price target, while Jefferies anchored the low end with a Hold rating and a $28 target. The coordinated initiations reflect a recently public company emerging from its IPO quiet period.
For watchful investors, the takeaway is straightforward: institutional consensus on X-Energy stock is constructive, but the wide dispersion in price targets signals genuine disagreement about valuing a pre-commercial nuclear story. X-Energy shares changed hands near $27.71 in Tuesday trading, fairly close to the 52-week low of $25.06 and well below the $37.10 high.
The analyst flurry arrives as the small modular reactor (SMR) theme remains one of the most debated trades in energy. X-Energy stock now sits at the center of that debate.
| Ticker | Company | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| XE | X-Energy | Guggenheim | Initiation | Buy | $57 |
| XE | X-Energy | Morgan Stanley | Initiation | Overweight | $41 |
| XE | X-Energy | UBS | Initiation | Buy | $40 |
| XE | X-Energy | JPMorgan | Initiation | Overweight | $38 |
| XE | X-Energy | TD Cowen | Initiation | Buy | $35 |
| XE | X-Energy | Jefferies | Initiation | Hold | $28 |
The Analyst’s Case
The bull thesis hinges on structural demand. X-Energy has been a notable beneficiary of the SMR investment thesis tied to AI data center power demand, U.S. energy security policy, and decarbonization needs. Guggenheim’s $57 price target sits at nearly double the Jefferies floor, signaling the most optimistic view sees significant commercialization upside.
Jefferies’s more cautious Hold call reflects the other side of the ledger. SMR commercialization timelines are long, regulatory approval risk is real, capital intensity is enormous, and first-of-a-kind project economics are uncertain. That tension between long-dated optionality and near-term execution risk defines the central debate around X-Energy stock.
Company Snapshot
X-Energy is a developer of advanced small modular reactor nuclear technology, specifically the Xe-100 high-temperature gas-cooled reactor designed for both grid power and industrial process heat applications. The company is headquartered in Rockville, Maryland.
X-Energy’s market capitalization stood near $7.53 billion as of May 19. Trailing revenue of $94.26 million and a diluted loss of $0.54 per share underscore that X-Energy remains in early innings of monetizing its reactor platform.
Why the Move Matters Now
The simultaneous launch from six bulge-bracket firms signals institutional momentum for X-Energy stock. The cluster of initiations on the same day is consistent with a recently IPO’d company emerging from a quiet period, and the five-to-one bullish skew suggests research desks broadly endorse the SMR opportunity.
The valuation context is unusual. X-Energy’s price-to-sales ratio of 79.2 and EV-to-revenue of 69.68 reflect a stock that’s priced on future deployments, not current cash flows. XE shares slipped sharply over the past week before bouncing 7% in Tuesday’s session, illustrating volatility that comes with that profile.
What It Means for Your Portfolio
X-Energy stock offers thematic exposure to the AI-plus-nuclear story without utility diversification. The five Buy or Overweight ratings provide institutional validation, yet the $28 to $57 target range reminds investors that professionals disagree on fair value.
A measured approach makes sense. Position sizing should reflect the binary nature of SMR commercialization, and patient capital may be rewarded if the Xe-100 reaches deployment milestones on schedule.
Watch for whether quarterly updates show progress on regulatory filings and customer contracts for X-Energy. Those data points, more than any single price target, will determine whether the bullish skew in this initial Wall Street coverage proves prescient.
Top Gaining Stocks
Top Losing Stocks